
PhRMA Spends Record Lobbying Sum to Keep Drug Prices High
In the first quarter of the year, Big Pharma’s top lobbying group spent a record-breaking $12.9 million on federal lobbying—an unprecedented blitz that coincided with a string of Trump administration decisions benefiting drugmakers. As the industry secured …